Chemerin causes lipid metabolic imbalance and induces passive lipid accumulation in human hepatoma cell line via the receptor GPR1
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chemerin causes lipid metabolic imbalance and induces passive lipid accumulation in human hepatoma cell line via the receptor GPR1
Authors
Keywords
Chemerin, GPR1, Lipogenesis, Fatty acid oxidation, Hepatocyte
Journal
LIFE SCIENCES
Volume 278, Issue -, Pages 119530
Publisher
Elsevier BV
Online
2021-04-20
DOI
10.1016/j.lfs.2021.119530
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intermittent Fasting and “Metabolic Switch”: Effects on Metabolic Syndrome, Pre‐diabetes and Type 2 Diabetes Mellitus
- (2020) Aman Rajpal et al. DIABETES OBESITY & METABOLISM
- Effect of Bariatric Surgery on the Circulating Level of Adiponectin, Chemerin, Plasminogen Activator Inhibitor-1, Leptin, Resistin, and Visfatin: A Systematic Review and Meta-Analysis
- (2020) Moein Askarpour et al. HORMONE AND METABOLIC RESEARCH
- Metabolic Impact of Flavonoids Consumption in Obesity: From Central to Peripheral
- (2020) Viviana Sandoval et al. Nutrients
- Chemerin Added to Endothelin-1 Promotes Rat Pulmonary Artery Smooth Muscle Cell Proliferation and Migration
- (2020) Aliénor Hanthazi et al. Frontiers in Physiology
- Chemerin Isoform-Specific Effects on Hepatocyte Migration and Immune Cell Inflammation
- (2020) Susanne Feder et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Chemerin-156 is the Active Isoform in Human Hepatic Stellate Cells
- (2020) Marlen Spirk et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Impact of GPR1 Signaling on Maternal High-fat Feeding and Placenta Metabolism in Mice
- (2019) Binbin Huang et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Molecular characterization, expression analysis of Chemerin gene and its potential role in intramuscular adipocyte differentiation of goat
- (2019) Jieqiong Ma et al. ANIMAL BIOTECHNOLOGY
- Chemerin and Cancer
- (2019) Oliver Treeck et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Chemerin-9, a potent agonist of chemerin receptor (ChemR23), prevents atherogenesis
- (2019) Kengo Sato et al. CLINICAL SCIENCE
- Expression of Chemerin and Its Receptors in the Porcine Hypothalamus and Plasma Chemerin Levels during the Oestrous Cycle and Early Pregnancy
- (2019) Nina Smolinska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Renal Chemerin Expression is Induced in Models of Hypertensive Nephropathy and Glomerulonephritis and Correlates with Markers of Inflammation and Fibrosis
- (2019) Alexander Mocker et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Anaphylatoxin C5a induces inflammation and reduces insulin sensitivity by activating TLR4/NF-kB/PI3K signaling pathway in 3T3-L1 adipocytes
- (2018) Xin-Yan Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Chemerin suppresses neuroinflammation and improves neurological recovery via CaMKK2/AMPK/Nrf2 pathway after germinal matrix hemorrhage in neonatal rats
- (2018) Yixin Zhang et al. BRAIN BEHAVIOR AND IMMUNITY
- FAM3 gene family: A promising therapeutical target for NAFLD and type 2 diabetes
- (2018) Xiaoyan Zhang et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Chemerin in human cardiovascular disease
- (2018) Jaspreet Kaur et al. VASCULAR PHARMACOLOGY
- The Effect of Hypoxia and Metformin on Fatty Acid Uptake, Storage, and Oxidation in L6 Differentiated Myotubes
- (2018) Martina Musutova et al. Frontiers in Endocrinology
- Serum chemerin is associated with inflammatory and metabolic parameters-results of a population-based study
- (2017) Stephanie Zylla et al. Obesity
- International Union of Basic and Clinical Pharmacology CIII: Chemerin Receptors CMKLR1 (Chemerin1) and GPR1 (Chemerin2) Nomenclature, Pharmacology, and Function
- (2017) Amanda J. Kennedy et al. PHARMACOLOGICAL REVIEWS
- Deferoxamine ameliorates hepatosteatosis via several mechanisms inob/obmice
- (2016) Han Xue et al. Annals of the New York Academy of Sciences
- Serum Chemerin in Obese Children and Adolescents Before and After L-Carnitine Therapy: Relation to Nonalcoholic Fatty Liver Disease and Other Features of Metabolic Syndrome
- (2016) Rasha T. Hamza et al. ARCHIVES OF MEDICAL RESEARCH
- Adipokines in nonalcoholic fatty liver disease
- (2016) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Chemokine-Like Receptor 1 Is a Novel Wnt Target Gene that Regulates Mesenchymal Stem Cell Differentiation
- (2016) Shanmugam Muruganandan et al. STEM CELLS
- Adaptation of Hepatic Mitochondrial Function in Humans with Non-Alcoholic Fatty Liver Is Lost in Steatohepatitis
- (2015) Chrysi Koliaki et al. Cell Metabolism
- CMKLR1 and GPR1 mediate chemerin signaling through the RhoA/ROCK pathway
- (2015) Jillian L. Rourke et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Kinsenoside-mediated lipolysis through an AMPK-dependent pathway in C3H10T1/2 adipocytes
- (2015) Kur-Ta Cheng et al. PHYTOMEDICINE
- Low dose aspirin is associated with plasma chemerin levels and may reduce adipose tissue inflammation
- (2014) Magdalena Herová et al. ATHEROSCLEROSIS
- Chemerin and CMKLR1 expression in human arteries and periadventitial fat: a possible role for local chemerin in atherosclerosis?
- (2014) Christos G Kostopoulos et al. BMC Cardiovascular Disorders
- Development of a Membrane-anchored Chemerin Receptor Agonist as a Novel Modulator of Allergic Airway Inflammation and Neuropathic Pain
- (2014) Jamie R. Doyle et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genome Wide Meta-analysis Highlights the Role of Genetic Variation in RARRES2 in the Regulation of Circulating Serum Chemerin
- (2014) Anke Tönjes et al. PLoS Genetics
- Cloning of porcine chemerin, ChemR23 and GPR1 and their involvement in regulation of lipogenesis
- (2011) Jianfeng Huang et al. BMB Reports
- Nobiletin Attenuates VLDL Overproduction, Dyslipidemia, and Atherosclerosis in Mice With Diet-Induced Insulin Resistance
- (2011) E. E. Mulvihill et al. DIABETES
- Chemerin Exacerbates Glucose Intolerance in Mouse Models of Obesity and Diabetes
- (2010) Matthew C. Ernst et al. ENDOCRINOLOGY
- Sterol Regulatory Element-Binding Protein 2 (SREBP2) Activation after Excess Triglyceride Storage Induces Chemerin in Hypertrophic Adipocytes
- (2010) Sabrina Bauer et al. ENDOCRINOLOGY
- Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity1
- (2010) Nirupa Sachithanandan et al. HEPATOLOGY
- Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes
- (2009) Johanna Weigert et al. CLINICAL ENDOCRINOLOGY
- Chemerin Is a Novel Adipocyte-Derived Factor Inducing Insulin Resistance in Primary Human Skeletal Muscle Cells
- (2009) Henrike Sell et al. DIABETES
- Interleukin-1ß induces the novel adipokine chemerin in adipocytes in vitro
- (2009) Susan Kralisch et al. REGULATORY PEPTIDES
- Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes
- (2008) Michiko Takahashi et al. FEBS LETTERS
- Regulation of Chemerin Bioactivity by Plasma Carboxypeptidase N, Carboxypeptidase B (Activated Thrombin-activable Fibrinolysis Inhibitor), and Platelets
- (2008) Xiao-Yan Du et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Role of neutrophil proteinase 3 and mast cell chymase in chemerin proteolytic regulation
- (2008) Aude Guillabert et al. JOURNAL OF LEUKOCYTE BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now